Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Yuchen Barrett"'
Autor:
Jessie Wang, John H. Alexander, Richard C. Becker, L K Newby, Lars Wallentin, H. Yang, Yuchen Barrett, Puneet Mohan, Robert A. Harrington
Publikováno v:
Thrombosis and Haemostasis. 104:976-983
SummaryApixaban is an oral, direct factor Xa inhibitor under development for secondary prevention in acute coronary syndrome (ACS). Apixaban‘s effect on D-dimer and prothrombin fragment 1.2 (F1.2) (coagulation activity biomarkers ) was determined i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3461cf569dfe9253497f784a9bf97a89
https://doi.org/10.1160/th10-04-0247
https://doi.org/10.1160/th10-04-0247
Autor:
Boris Gorovits, Gopi Shankar, Steven J. Swanson, Deborah Finco-Kent, Yuchen Barrett, Shalini Gupta, Holly W. Smith, Bonita Rup, Linda Zuckerman, Gary Taniguchi, Anthony Mire-Sluis, Valerie Quarmby, Michael Moxness, Viswanath Devanarayan, Thomas Parish, Elizabeth Shores, Eugen Koren, Christopher Stebbins
Publikováno v:
Journal of Immunological Methods. 333:1-9
The appropriate evaluation of the immunogenicity of biopharmaceuticals is of major importance for their successful development and licensure. Antibodies elicited by these products in many cases cause no detectable clinical effects in humans. However,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad223c81deef9c582855cc5214e57742
https://doi.org/10.1016/j.jim.2008.01.001
https://doi.org/10.1016/j.jim.2008.01.001
Autor:
John H. Alexander, Lars Wallentin, Hongqiu Yang, Richard C. Becker, Jessie Wang, Puneet Mohan, Yuchen Barrett
Publikováno v:
Journal of thrombosis and thrombolysis. 32(2)
An ability to readily determine an anticoagulant effect with an emerging class of direct, active site, oral factor Xa inhibitors is viewed by the medical community as attractive and by some as an absolute requirement for their use in clinical practic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ed229b84bea9b36653c1c018e4963f3
https://pubmed.ncbi.nlm.nih.gov/21516308
https://pubmed.ncbi.nlm.nih.gov/21516308
Autor:
Jessie Wang, Richard C. Becker, Honqqui Yang, John H. Alexander, Yuchen Barrett, Robert A. Harrington, Lars Wallentin
Publikováno v:
Journal of the American College of Cardiology. 55:A102.E950
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d77b195aa51539f168c52049c65e2f1
https://doi.org/10.1016/s0735-1097(10)60951-5
https://doi.org/10.1016/s0735-1097(10)60951-5
Autor:
John H. Alexander, Yuchen Barrett, Puneet Mohan, Jessie Wang, Hongqiu Yang, Richard C. Becker, Annie Lin
Publikováno v:
Journal of the American College of Cardiology. (14):E1039
APPRAISE-1 was an international, multicenter, randomized, double-blinded placebo-controlled, dose escalation trial. Eligible patients were between 18 and 92 years of age, had a recent (within 7 days) ST segment elevation or non-ST segment elevation A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed0987e4827d8b1f8333f35bccaeda1f